You are here

Avadel Pharma

Jazz Pharma sues FDA over approval of rival narcolepsy drug

Medical Marketing and Media

Tue, 06/27/23 - 11:29 am

With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market

Fierce Pharma

Tue, 05/2/23 - 11:41 am

FTC Amicus Brief Challenges Abuse of FDA “Orange Book” Listing Procedures to Block Drug Competition

FTC

Sun, 11/13/22 - 06:56 pm

Jazz Pharmaceuticals

July Brings Layoffs, Job Creation for the Life Sciences

BioSpace

Wed, 08/3/22 - 09:32 pm

Eikon Therapeutics

Heron Therapeutics

Adverum Biotechnologies

X4 Pharmaceuticals

Assembly Biosciences